secwatch.observer — SEC 8-K summary
======================================

Issuer:     Propanc Biopharma, Inc. (PPCB)
CIK:        0001517681
Form:       8-K
Filed at:   2023-02-22T23:59:59+00:00
Accession:  0001493152-23-005757
Event type: debt
Sentiment:  neutral
Materiality: 0.40
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Propanc Biopharma retires final convertible note via full conversion to common stock
--------------------------------------------------------------------------------

- Retired final convertible promissory note dated June 30, 2022, with 1800 Diagonal Lending LLC.
- Full payment made on Feb 15, 2023, converting all outstanding principal and interest into common stock.
- Zero balance remaining; no further obligations to issue securities to the holder.
- No specific financial impact or conversion terms disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1517681/000149315223005757/0001493152-23-005757-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1517681/000149315223005757/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-005757

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer